[go: up one dir, main page]

GB0408199D0 - Liquids containing suspended sugar glass particles - Google Patents

Liquids containing suspended sugar glass particles

Info

Publication number
GB0408199D0
GB0408199D0 GBGB0408199.8A GB0408199A GB0408199D0 GB 0408199 D0 GB0408199 D0 GB 0408199D0 GB 0408199 A GB0408199 A GB 0408199A GB 0408199 D0 GB0408199 D0 GB 0408199D0
Authority
GB
United Kingdom
Prior art keywords
glass particles
liquids containing
containing suspended
particles
sugar glass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0408199.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NOVA BIO-PHARMA TECHNOLOGIES LIMITED
Original Assignee
Cambridge Biostability Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd filed Critical Cambridge Biostability Ltd
Priority to GBGB0408199.8A priority Critical patent/GB0408199D0/en
Publication of GB0408199D0 publication Critical patent/GB0408199D0/en
Priority to GB0504501A priority patent/GB2413075B/en
Priority to US10/599,928 priority patent/US20080026066A1/en
Priority to KR1020067022106A priority patent/KR20070009639A/en
Priority to ES05731023T priority patent/ES2339783T3/en
Priority to AU2005232441A priority patent/AU2005232441B2/en
Priority to CA002562606A priority patent/CA2562606A1/en
Priority to PCT/GB2005/050050 priority patent/WO2005099669A1/en
Priority to DE602005019398T priority patent/DE602005019398D1/en
Priority to MXPA06011895A priority patent/MXPA06011895A/en
Priority to PT05731023T priority patent/PT1750668E/en
Priority to EP05731023A priority patent/EP1750668B1/en
Priority to DK05731023.7T priority patent/DK1750668T3/en
Priority to CN2005800110373A priority patent/CN1942171B/en
Priority to RU2006137275/15A priority patent/RU2363447C2/en
Priority to AT05731023T priority patent/ATE457717T1/en
Priority to JP2007507853A priority patent/JP2007532619A/en
Priority to ZA200609158A priority patent/ZA200609158B/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)

Abstract

A pharmaceutical composition comprising a biologically active agent preserved in particulate form, in particular a glass or amorphous particle, such as a sugar, a metal carboxylate, an amino acid or calcium phosphate, wherein said particles are suspended in at least one of a hydrofluoroether, a perfluoroether, a hydrofluoroamine, a perfluoroamine, a hydrofluorothioether, a perfluorothioether, a hydrofluoropolyether or a perfluoropolyether. The use of such fluorinated liquid media overcomes the problem of aggregation of particles and also is environmentally friendly.
GBGB0408199.8A 2004-04-13 2004-04-13 Liquids containing suspended sugar glass particles Ceased GB0408199D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB0408199.8A GB0408199D0 (en) 2004-04-13 2004-04-13 Liquids containing suspended sugar glass particles
GB0504501A GB2413075B (en) 2004-04-13 2005-03-07 Liquids containing suspended glass particles
JP2007507853A JP2007532619A (en) 2004-04-13 2005-04-13 Liquid containing suspended glass particles
DE602005019398T DE602005019398D1 (en) 2004-04-13 2005-04-13 LIQUIDS WITH SUSPENDED GLASS PARTICLES
EP05731023A EP1750668B1 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
ES05731023T ES2339783T3 (en) 2004-04-13 2005-04-13 LIQUIDS CONTAINING SUSTAINED VITREAS PARTICLES.
AU2005232441A AU2005232441B2 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
CA002562606A CA2562606A1 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
PCT/GB2005/050050 WO2005099669A1 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
US10/599,928 US20080026066A1 (en) 2004-04-13 2005-04-13 Liquids Containing Suspended Glass Particles
MXPA06011895A MXPA06011895A (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles.
PT05731023T PT1750668E (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
KR1020067022106A KR20070009639A (en) 2004-04-13 2005-04-13 Liquid containing suspended glass particles
DK05731023.7T DK1750668T3 (en) 2004-04-13 2005-04-13 Liquids containing suspended glass particles
CN2005800110373A CN1942171B (en) 2004-04-13 2005-04-13 liquid containing suspended glassy particles
RU2006137275/15A RU2363447C2 (en) 2004-04-13 2005-04-13 Liquid, containing suspended vitreous particles
AT05731023T ATE457717T1 (en) 2004-04-13 2005-04-13 LIQUIDS WITH SUSPENDED GLASS PARTICLES
ZA200609158A ZA200609158B (en) 2004-04-13 2006-11-03 Liquids containing suspended glass particles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0408199.8A GB0408199D0 (en) 2004-04-13 2004-04-13 Liquids containing suspended sugar glass particles

Publications (1)

Publication Number Publication Date
GB0408199D0 true GB0408199D0 (en) 2004-05-19

Family

ID=32320732

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0408199.8A Ceased GB0408199D0 (en) 2004-04-13 2004-04-13 Liquids containing suspended sugar glass particles
GB0504501A Expired - Lifetime GB2413075B (en) 2004-04-13 2005-03-07 Liquids containing suspended glass particles

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0504501A Expired - Lifetime GB2413075B (en) 2004-04-13 2005-03-07 Liquids containing suspended glass particles

Country Status (10)

Country Link
CN (1) CN1942171B (en)
AT (1) ATE457717T1 (en)
DE (1) DE602005019398D1 (en)
DK (1) DK1750668T3 (en)
ES (1) ES2339783T3 (en)
GB (2) GB0408199D0 (en)
MX (1) MXPA06011895A (en)
PT (1) PT1750668E (en)
RU (1) RU2363447C2 (en)
ZA (1) ZA200609158B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB0523638D0 (en) 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US9243626B2 (en) 2012-11-19 2016-01-26 Nordson Corporation Adhesive dispensing system and method including a pump with integrated diagnostics

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07258027A (en) * 1994-03-16 1995-10-09 Shiseido Co Ltd Makeup cosmetic
US6433040B1 (en) * 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6190701B1 (en) * 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
AU2046101A (en) * 1999-11-22 2001-06-04 Universal Preservation Technologies, Inc. Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
US6562872B1 (en) * 2000-07-20 2003-05-13 Otkrytoe Aktsionernoe Obschestvo Naucho-Proizvodstven-Naya Firma “Perftoran” Emulsion of perfluoroorganic compounds for medical purposes, a process for the preparation thereof and methods for treating and preventing diseases with the use thereof
PL360052A1 (en) * 2000-10-13 2004-09-06 Cambridge Biostability Ltd. Composition and method for stable injectable liquids

Also Published As

Publication number Publication date
GB2413075A (en) 2005-10-19
DK1750668T3 (en) 2010-05-10
ES2339783T3 (en) 2010-05-25
ZA200609158B (en) 2008-06-25
MXPA06011895A (en) 2007-11-20
RU2006137275A (en) 2008-05-20
DE602005019398D1 (en) 2010-04-01
ATE457717T1 (en) 2010-03-15
CN1942171B (en) 2011-04-06
PT1750668E (en) 2010-04-07
GB0504501D0 (en) 2005-04-13
GB2413075B (en) 2009-01-21
CN1942171A (en) 2007-04-04
RU2363447C2 (en) 2009-08-10

Similar Documents

Publication Publication Date Title
EP2335575A3 (en) Magnetic gas bubble composition and magnetic gas bubble precursor for its manufacture
UA96473C2 (en) Liquid stable formulation comprising imc-a12 antibody
GB2464038A (en) System, method, and apparatus for combined fracturing treatment and scale inhibition
UA106925C2 (en) Probiotic compositions and the device for their introduction
WO2004058156A3 (en) High pressure spray-dry of bioactive materials
EP2293808A4 (en) SYNTHETIC PEPTIDE CONTAINING OSTEOGENIC PEPTIDE 1 (BFP 1) FOR THE STIMULATION OF OSTEOBLASTIC DIFFERENTIATION, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SYNTHETIC PEPTIDE
MX271467B (en) Personal cleansing composition containing irregularly shaped particles and spherical particles.
DE502004007577D1 (en) Lymerpartikel
IL160931A0 (en) Powder processing with pressurized gaseous fluids
PL2007863T3 (en) Granulates for a sensitive washing- or cleaning agent containing material
CA2521007A1 (en) Particulate material containing thermoplastic elastomer and methods for making and using same
BR0214279A (en) Pharmaceutical compositions in particulate form
NZ596876A (en) Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
NZ594136A (en) Delivery of bound material from body to surface using ultrasonic signal
WO2006137934A3 (en) Purposeful movement of human migratory cells away from an agent source
MXPA05013147A (en) Solid pharmaceutical preparation.
SE0100823D0 (en) Method I to obtain microparticles
UA96145C2 (en) Fat-containing composition and method for improving solubility of fat-containing powders in cold liquids
WO2009060608A1 (en) Sustained release composition containing sdf-1
NZ599292A (en) Vitamin d compositions and method of administration to a human being
MA31927B1 (en) Pharmaceutical compositions containing at least an active protein base, protect digestive enzymes
FR2881648B1 (en) COSMETIC COMPOSITION COMPRISING A POLYMER PARTICLE DISPERSION, POLYMER PARTICLE DISPERSION AND COSMETIC PROCESS USING THE SAME
GB2413075B (en) Liquids containing suspended glass particles
DE502005009045D1 (en) MAGNETORHEOLOGICAL MATERIALS WITH HIGH SWITCHING FACTOR AND ITS USE
TR200102988T2 (en) Absorbents for use in handling complex liquids.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)
COOA Change in applicant's name or ownership of the application

Owner name: NOVA BIO-PHARMA TECHNOLOGIES LIMITED

Free format text: FORMER OWNER: CAMBRIDGE BIOSTABILITY LIMITED